Director Carey Oconnor Kolaja sold $71K of Revance Therapeutics, Inc.

Sold$70,600

$28.24Price

2,500Shares

−13%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Thu, Jun 15. Filed Tue, Jun 20, 12:25 PM ET, during the session. Not investment advice.